Acne Vulgaris
📧 Sign up to get email alerts when something new happens for Acne Vulgaris.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-06-10FDA Approved: TRETINOIN — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's supplemental application for tretinoin (generic) under ANDA 208279, authorizing continued or expanded marketing of t…
-
CLINICAL_TRIALS trial_result · 2024-05-28Clinical Trial Update: Association of Acne Vulgaris With Oral Hygiene and Gingivitis
A clinical trial update from Erzincan University notes a study examining the relationship between acne vulgaris and oral hygiene factors lik…
-
CLINICAL_TRIALS trial_result · 2024-05-21Clinical Trial Update: Evaluation of Safety and Performance of Ialuxid Gel in Treatment of Acne Vulgaris, and Folliculitis [NA]
This clinical trial update confirms the completion of a study evaluating the safety and performance of Ialuxid Gel in treating acne vulgaris…
-
CLINICAL_TRIALS trial_result · 2024-05-20Clinical Trial Update: Evaluation of the Safety and Efficacy of an Acne Treatment Device [NA]
A completed clinical trial evaluated the safety and efficacy of a ZIIP Beauty acne treatment device for mild to moderate acne.
-
CLINICAL_TRIALS research · 2024-05-07Clinical Trial Update: Feasibility Study to Collect and Assess Safety Data for a Radiofrequency Microneedling Device for Electrocoagulation and Hemostasis of Soft Tissues for Dermatologic Conditions [NA]
Clinical trial update describing a feasibility study to collect safety data on a radiofrequency microneedling device used for electrocoagula…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-04-29FDA Approved: TRETINOIN — Original Application (Alembic Pharmaceuticals Inc.)
FDA lists Alembic Pharmaceuticals' generic tretinoin as approved in its Original Application (ANDA) for topical treatment of acne vulgaris.
-
FDA approval · 2024-04-25FDA Approved: TRETINOIN — Original Application (Viona Pharmaceuticals Inc)
FDA approved the original application for tretinoin from Viona Pharmaceuticals, authorizing a generic topical tretinoin product (for acne vu…
-
CLINICAL_TRIALS trial_result · 2024-04-15Clinical Trial Update: Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris [Phase 3]
Phase 3 trial evaluating the efficacy and safety of adapalene/benzoyl peroxide topical gel in Acne Vulgaris has completed and results posted…
-
FDA approval · 2024-04-11FDA Approved: ADAPALENE AND BENZOYL PEROXIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for Adapalene and Benzoyl Peroxide from Sun Pharmaceutical Industries, expanding the approval of…
-
CLINICAL_TRIALS trial_result · 2024-04-03Clinical Trial Update: Serum Intercellular Adhesion Molecule -1 in Acne Vulgaris Patients : Effect of Montelukast [Phase 3]
Phase 3 clinical trial evaluating montelukast for acne vulgaris, focusing on serum ICAM-1 as a biomarker; not yet recruiting.
-
FDA approval · 2024-03-14FDA Approved: DOXYCYCLINE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' original application for doxycycline, a generic antibiotic, expanding the availability of doxycycline pr…
-
FDA approval · 2024-03-06FDA Approved: AZELAIC ACID — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for azelaic acid by Actavis Pharma, expanding/updating its labeling.
-
FDA approval · 2024-03-04FDA Approved: CLARAVIS — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for CLARAVIS (isotretinoin) from Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2024-03-04FDA Approved: CLARAVIS — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Claravis (isotretinoin) submitted by Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2024-02-23FDA Approved: CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a supplemental application for Clindamycin Phosphate and Benzoyl Peroxide by Padagis Israel Pharmaceuticals Ltd.
-
FDA approval · 2024-02-20FDA Approved: AZELEX — Supplemental Application (Almirall, LLC)
FDA supplemental application for AZELEX (azelaic acid) submitted by Almirall, LLC.
-
FDA approval · 2024-02-16FDA Approved: ISOTRETINOIN — Supplemental Application (Mayne Pharma)
FDA approved a supplemental application for isotretinoin by Mayne Pharma, expanding the labeling for acne vulgaris.
-
CLINICAL_TRIALS trial_result · 2024-02-09Clinical Trial Update: Comparative Study of Metformin Versus Doxycycline in Moderate to Severe Adult Acne Vulgaris Patients. [Phase 2]
A Phase 2 clinical trial compares metformin versus doxycycline in adults with moderate to severe acne vulgaris; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2024-02-01Clinical Trial Update: Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris [Phase 3]
Phase 3 clinical trial comparing IDP-126 Gel for acne vulgaris has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2024-02-01Clinical Trial Update: Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris [Phase 3]
Phase 3 clinical trial comparing IDP-126 Gel for acne vulgaris has completed with results posted in early 2024.
-
FDA approval · 2024-01-29FDA Approved: ISOTRETINOIN — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's original ANDA for isotretinoin (generic isotretinoin). Isotretinoin is used to treat severe acne vul…
-
FDA approval · 2023-12-27FDA Approved: ADAPALENE — Supplemental Application (Mayne Pharma Commercial LLC.)
FDA approved a supplemental application for adapalene submitted by Mayne Pharma Commercial LLC.
-
CLINICAL_TRIALS trial_result · 2023-12-20Clinical Trial Update: AkLief Evaluation in Acne-induced Post-Inflammatory Hyperpigmentation [Phase 4]
Phase 4 trial update for AkLief in acne vulgaris with evaluation of acne-induced post-inflammatory hyperpigmentation completed with results …
-
FDA approval · 2023-12-14FDA Approved: ADAPALENE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Adapalene by Sun Pharmaceutical Industries. The action concerns the product's approved indicatio…
-
CLINICAL_TRIALS trial_result · 2023-11-03Clinical Trial Update: Toxicity and Efficacy Evaluation of Topical Minoxidil in Acne Vulgaris [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating the toxicity and efficacy of topical minoxidil for acne vulgaris.